Cutera (NASDAQ:CUTR) released its quarterly earnings data on Thursday. The medical device company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.23, Briefing.com reports. The company had revenue of $46.12 million for the quarter, compared to the consensus estimate of $41.66 million. Cutera had a negative return on equity of 69.92% and a negative net margin of 20.49%. The company’s quarterly revenue was up 13.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.11 earnings per share.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
NASDAQ CUTR traded up $3.75 during trading on Friday, reaching $36.28. 764,700 shares of the company traded hands, compared to its average volume of 170,393. The stock’s 50 day moving average price is $30.12 and its two-hundred day moving average price is $24.67. The company has a market cap of $466.84 million, a price-to-earnings ratio of -16.27 and a beta of 0.88. Cutera has a 1-year low of $12.32 and a 1-year high of $38.88. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.16 and a current ratio of 1.67.
CUTR has been the topic of a number of recent research reports. Maxim Group reaffirmed a “hold” rating on shares of Cutera in a report on Friday, August 9th. Zacks Investment Research raised Cutera from a “hold” rating to a “buy” rating and set a $35.00 price objective on the stock in a report on Tuesday, October 29th. ValuEngine raised Cutera from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Stephens lifted their price objective on Cutera from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday. Finally, Sidoti downgraded Cutera from a “buy” rating to a “neutral” rating in a report on Thursday, August 22nd. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $40.00.
Cutera Company Profile
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Featured Article: Blockchain